Cell size control - a mechanism for maintaining fitness and function by Miettinen, TP et al.
 1 
 
Problems & Paradigms 
 
Cell size control - a mechanism for maintaining fitness and function 
 5 
Teemu P. Miettinen1)2), Matias J. Caldez3)4), Philipp Kaldis3)4) and Mikael 
Björklund5)* 
1) MRC Laboratory for Molecular Cell Biology, University College London, London, 
UK 
2) Koch Institute for Integrative Cancer Research, Massachusetts Institute of 10 
Technology, Cambridge, MA, USA 
3) Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, 
Technology and Research), Singapore  
4) Department of Biochemistry, National University of Singapore (NUS), Singapore  
5) Division of Cell and Developmental Biology, School of Life Sciences, University of 15 




E-mail: mikael.bjorklund.lab@gmail.com 20 
 
Keywords: cell size control; fitness; metabolism; mevalonate pathway; mitochondria; 






The maintenance of cell size homeostasis has been studied for years in different 5 
cellular systems. With the focus on ‘what regulates cell size’, the question ‘why cell 
size needs to be maintained’ has been largely overlooked. Recent evidence indicates 
that animal cells exhibit nonlinear cell size dependent growth rates and mitochondrial 
metabolism, which are maximal in intermediate sized cells within each cell 
population. Increases in intracellular distances and changes in the relative cell surface 10 
area impose biophysical limitations on cells, which can explain why growth and 
metabolic rates are maximal in a specific cell size range. Consistently, aberrant 
increases in cell size, for example through polyploidy, are typically disadvantageous 
to cellular metabolism, fitness, and functionality. Accordingly, cellular hypertrophy 
can potentially predispose to or worsen metabolic diseases. We propose that cell size 15 
control may have emerged as a guardian of cellular fitness and metabolic activity. 
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Introduction: Cell size control models 
Cell size is closely associated with cell division, as most cells need to grow and 
increase their size before they can divide. Research on cell size has mainly focused on 
identification of molecular mechanisms linking growth and cell cycle, particularly if 
and how key cell cycle phases, such as initiation of DNA synthesis, are dependent on 5 
cell size. This body of work has been extensively reviewed (see [1-3]). Another area of 
interest has been the development of phenomenological models how cell size 
homeostasis is achieved. The most prominent models, at least until recently, were the 
“sizer” and “timer” models. The “sizer” model assumes that the cell begins to divide 
once it reaches a critical size, whereas the “timer” model suggests that the cell grows 10 
for a specific amount of time prior to dividing [4]. These models require that cells can 
either measure their size or time, respectively. As neither of the models has gained 
universal acceptance, recent interest in bacterial size control has resulted in 
resurrection of the ~40 years old “incremental” [4] a.k.a. “adder” model [5]. The 
“adder” model postulates that cells add a constant volume (or mass) between birth and 15 
cell division. The constant volume addition means that smaller cells add more volume, 
in relative terms, during each cell cycle compared to larger cells. Thus, size 
homeostasis is automatically achieved by mean reversion as the daughter cell size 
corrects itself towards the normal size. In bacteria as well as budding yeast, the 
observed cell growth is consistent with the adder model [5-7]. There is less data from 20 
other model organisms but at least plant cell growth does not fit perfectly with the 
adder model [8]. 
The current models have been very informative, but they depend on cell 
proliferation. Instead, most animal cell types in vivo are terminally differentiated and 
not proliferating, yet they maintain size homeostasis. Non-dividing cells clearly cannot 25 
use cell division cycle for size adjustment, instead they likely rely on the balance 
between biosynthesis and degradation [9]. Such regulation may be even 
counterintuitive as cell size can increase when protein biosynthesis is reduced, 
provided that there is an even more pronounced reduction in catabolism [10]. There is 
a common misconception that non-proliferating cells are metabolically inactive. While 30 
this may be true for quiescent lymphocytes [11,12], some fibroblasts display metabolic 
activity comparable to proliferating cells [13], and neurons are well-known for their 
high metabolic activity, which is partly required for cellular “housekeeping” [14]. 
Hepatocytes are yet another example of a metabolically active but non-proliferating 
cell type. 35 
 A key unresolved question is whether cell size control is active or a passive 
consequence of underlying growth-laws that dictate the rate of cell division or 
initiation of DNA replication in proliferating cells [15]. The adder model favors a 
passive mechanism for the maintenance of cell size and size distribution within the cell 
population. On the other hand, the apparent uniformity of cell sizes (including non-40 
dividing cells in most animal tissues), suggests that cell size homeostasis is important 
and should thus be actively maintained [16]. The main limitation of the adder model is 
that it cannot easily explain why larger cells would add less (in relative terms) and 
smaller cells add more volume (again in relative terms) during the cell cycle [17]. To 
achieve constant volume addition, abnormally small and large cells would require a 45 
cell size or growth rate sensing mechanism that is somehow linked to cell cycle 
machinery to maintain size uniformity [16]. Slowing down cell cycle transitions for 
smaller cells would result in an adder-like behavior as small cells would have time to 
grow for a longer time before initiating DNA synthesis or mitosis. In addition to the 
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mechanisms controlling cell growth and/or division rate, cell size homeostasis could 
potentially also be achieved through size dependent cell death [18]. 
The existence of a mechanism that couples animal cell size to cell cycle and 
involves active and cell-autonomous size sensing has been often challenged. In some 
models, where growth factor and mitogen levels are fully controlled, growth and cell 5 
cycle can be uncoupled [19]. While these models allow cell size to be studied 
independently of proliferation, it is possible that the manipulation of the extracellular 
factors has downstream signaling effects that turn on or off the mechanism(s) that 
normally couple(s) growth and division (Table 1). Based on available evidence, at 
least animal cells have an apparent ability to sense their size [16]. It remains to be 10 
established whether this apparent size sensing is universal among organisms and if 
there is a unifying molecular mechanism, such as volume dependent dilution of a cell 
division regulatory protein [20] or growth rate [21]. However, it cannot be excluded 
that cell size is not monitored by any means and is simply an emergent property 
resulting from growth and cell division homeostasis [9,22]. 15 
 
Cell size connects to cellular growth rate 
The relationship between size and growth rate has been the prime inspiration 
for biologists working on size control. Although the correlation between growth rate 
and cell size was observed in bacteria already in the 1950’s and 1960’s [23-25], there 20 
is still no clear agreement how growth and size scale with each other. This lack of 
consensus can possibly be explained through fundamental differences between 
prokaryotes, single-celled eukaryotes and multicellular organisms, but also by 
different means of measurements (e.g. mass, volume or an indirect proxy such as light 
scattering or an amine reactive fluorescent probe), data fitting (e.g. single or multiple 25 
fit across the cell cycle) and normalisation (e.g. absolute or relative growth). For 
example, impressions drawn from absolute and cell size-normalised data regarding 
growth rate can be very different although the underlying data is identical (see Fig. 1A 
& B). Therefore, the lack of standardized methodology may have hampered the 
progress in this field (Table 1). 30 
While a faster growth rate typically results in larger cells, this is true mostly if 
populations of cells growing under different nutrient conditions are compared. Instead, 
if one compares cells within a population, a different picture typically emerges. For 
example, in budding yeast the correlation between cell size and growth rate is 
negative, bigger cells growing slower than smaller ones despite having more 35 
ribosomes for translation [26]. Consistently, yeast growth is fastest early in the cell 
cycle and growth substantially slows down at the G1/S boundary [27]. In multicellular 
organisms, recent evidence has indicated that growth is nonlinear and declines in 
largest cells [8,28-31]. Animal cells seem to initially increase their growth rate with 
increasing cell size (indicative of exponential growth) after which growth plateaus or 40 
is even reduced (Fig. 1A & B). 
 
Metabolism, not just ribosomes, drives growth 
The early observations of exponential bacterial growth were explained through 
ribosomal content and, consequently, translation being increased in larger cells [25]. It 45 
has been reported that ribosome content correlates with the growth rate in animals as 
well [32], and that cell growth is limited by protein synthesis [33]. In other words, 
translation has been seen as the main factor determining cell size, which was likely 
also part of the reason leading to the dominance of a TOR pathway-centred view on 
cell size control [34,35]. However, there are potential issues with this ribosome-50 
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oriented thinking for explaining cell size control. First, while the number of ribosomes 
typically increases with cell size and this supports faster growth, it does not 
necessarily mean that ribosomal content is the key limiting factor for growth. As 
mentioned above, growth is commonly nonlinear and declines in largest cells [8,28-
31]. Instead, one should ask, ‘what limits ribosomal activity in larger cells?’ Second, 5 
while ribosome amount or translational activity can limit cell size increase, it does not 
readily explain why cells prefer to be of certain size. 
Rates of transcription and translation depend on the metabolic activity of the 
cells [36,37]. In slow-growing yeast cells ribosome content appears to be limiting 
growth whereas under other conditions, oxygen dependent conversion of nutrients to 10 
ATP, appear more important [26]. Consistently, the amount of ATP generated equals 
approximately the energy requirements for protein synthesis across tens of different 
cell lines [30], highlighting the homeostasis in cellular energy production and 
consumption for biosynthesis, regardless of absolute ribosome number. On an 
organismal level, the metabolic rate, which is commonly measured as total oxygen 15 
consumption, is one of the best-established factors defining growth rate. In 1934 
Ludwig von Bertalanffy suggested that an animals’ growth rate was proportional to its 
metabolic rate. The metabolic rate declines with increasing organismal size, which is 
known as metabolic allometry [38]. Since allometry should also apply to individual 
cells [39], the cellular growth rate is expected to decline with increasing cell size. As 20 
mentioned earlier, evidence particularly from mammalian and plant cells support this 
concept that growth rate stagnates or is even reduced in larger cells [8,28-31]. These 
observations are consistent with the idea that while ribosomes can limit growth, the 
true limitation to cellular growth rate and cell size is the metabolic rate required to 
support translation and other growth processes. 25 
 
Cell size and cellular fitness & functionality 
Advances in cell size control models and mechanisms have been tremendous. 
Yet, we may have been sidetracked from the most important question: Why do cells 
need to maintain their size? While cell size is often mentioned to be important for 30 
cellular functionality from development to aging [40,41], it has not been widely 
appreciated how cell size specifically affects the organismal fitness and function, 
especially in multicellular organisms. 
A key finding from the bacterial in vitro evolution experiments performed in 
1990’s was the rapid co-evolution of cell volume and cellular fitness (as measured by 35 
growth rate) [42]. This link with cell size was observed possibly because the cells 
were directly selected to maximise their growth rate [15]. However, it is noteworthy 
that while there is a linear relationship between size and fitness/growth rate over a 
large range of bacterial cell sizes [42,43], specific environments or very large 
increases in cell size do reduce the fitness benefit of increased cell size in bacteria 40 
[43]. 
Fitness in animal cells is commonly measured as proliferative capacity using 
either non-quiescent cells in culture [44] or during tissue development such as in cell 
competition [45]. However, it is important to note that proliferative capacity 
(evolutionary fitness) may not be that relevant for individual cells in multicellular 45 
organisms as most cells within a tissue do not proliferate, and co-operate rather than 
compete. In this review we use fitness to describe the ability of cells and organisms to 
perform their specific function and their adaptability to cope when challenged (akin of 
physical fitness in athletes) rather than the more narrow evolutionary interpretation 
(reproductive fitness). 50 
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Because cellular fitness and the growth rate are connected in most in vitro 
experiments using proliferating cells, the cell size scaling of growth rate is likely to 
reflect the cell size scaling of cellular fitness. It is important to stress that ribosomal 
[26] or mitochondrial [46] functionality, rather than the quantity, appear to define the 
maximal growth rate and optimal fitness. While the scaling of organelles and 5 
intracellular structures with cell size has been appreciated [47], the activity of 
organelles does not always scale with size [46,48]. Therefore, simply having more 
ribosomes or mitochondria, or a larger spindle, may not always be beneficial for the 
cell [26,46,49] and may come at a cost. 
We recently demonstrated that in animal cells the intermediate cell size within 10 
a population (where growth rate is the highest) is linked to maximal fitness and 
optimal mitochondrial function [46]. This readily suggests that cell size is directly 
coupled to metabolism, i.e. metabolism is cell size dependent. At the same time, 
changes in metabolism are likely to be required to maintain and adjust cell size 
resulting in feedback between size and metabolism. Indeed, such a feedback between 15 
cell’s physical dimensions and metabolic capacity is considered a requirement for 
active cell size control [16]. 
 
Connecting metabolism and fitness to cell size in non-dividing cells 
The relationship between cell size and metabolic activity is likely to have 20 
consequences also in non-dividing cells. For example, as increased cell size is 
associated with reduced oxidative metabolic capacity, organisms are likely to be 
organized so that the cells which most dependent on high oxidative metabolism are 
small. As so often in biology, there are rules and exceptions. In skeletal muscle cells, 
there is an inverse relationship between oxidative metabolism and muscle fiber size. 25 
This is highlighted in muscles’ limited capacity for simultaneous increase in strength 
through hypertrophy and endurance capacity through increase in oxidative metabolism 
[50,51]. Consequently, the perceived fitness of the muscle cells depends on whether 
one measures fitness as an ability to perform resistance or endurance exercise. There 
are also conditions where mitochondrial activity declines when cell size is reduced. 30 
Muscle sarcopenia and neuronal atrophy during aging are probably the best examples. 
While the inverse relationship between size and metabolic activity is broken in these 
cases, cellular fitness correlates with the normal (optimal) cell size. Small but highly 
oxidative muscle fibers also illustrate the fallacy of thinking only in terms of growth 
rate. Small fibers are highly active biosynthetically but they also display a high 35 
turnover rate [50]. However, a major challenge is that we do not properly understand 
the causalities behind these relationships between cell size and metabolic activity. 
 
Challenges in validating the cell size and fitness hypothesis 
Different cell types display a characteristic cell size and intuitively this appears 40 
to be related to their function (Fig. 2). For example, leukocytes need to be small to be 
able to travel through tiny capillaries, whereas neurons are capable of faster signal 
propagation when relying on one long cell instead of several short ones. However, it 
may not be possible to define one single key function for each cell type, as cells are 
often pleiotropic. Thus, analysis of how fitness and functionality scales with cell size 45 
in certain cell types may be challenging. 
Experimental validation of cell size dependent fitness and functionality in 
animal cells will be hampered by difficulties in technical and experimental design 
(Table 1). Ideally, one should obtain high-resolution single-cell measurements of 
cellular functions and cell size under unperturbed conditions (as done in Fig. 1A & B) 50 
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and then use the natural variability in cell sizes to observe how functions scale with 
cell size. However, using this approach cell cycle dependent changes may mask the 
cell size effects and a substantial number of single-cells need to be analysed to 
separate cell size and cell cycle effects [46]. While this may be done in cultured cells, 
analysis of tissues is likely to be challenging. As an alternative approach, one should 5 
engineer mutants spanning a wide range of cell sizes without compromising normal 
cell cycle progression. All this makes it challenging to obtain non-circumstantial 
evidence that is needed to unravel the true relationship between cell size and cellular 
growth, fitness and functionality. We also need to acknowledge that there is unlikely 
to be one universal relationship that is applicable to all cell types under all 10 
circumstances. Currently, some of the best evidence for size dependent fitness and 
functionality comes from polyploid cells, which display vast increases in cell size.  
 
Polyploidy in cells and animals reduces fitness but may improve adaptation 
Ploidy is defined as the number of sets of chromosomes in a cell and the 15 
resulting DNA content is typically directly proportional to cell size. Thus, polyploid 
cells can potentially provide evidence for the importance of cell size, especially if cell 
size and ploidy effects can be distinguished. While ploidy and cell size correlate well, 
the cellular environment nevertheless plays an important role in determination of the 
final cell size even in polyploid cells [52,53]. A large body of experiments in yeast 20 
indicate that changes in ploidy and, consequently, cell size are typically detrimental 
[54], but under changing conditions increased ploidy may improve adaptation [55]. 
This may be related to the assumption that cell size needs to be adjusted for each 
condition to provide maximal fitness and to optimize organismal survival. However, 
as a consequence of polyplodization, dosage sensitive genes rather than physical size 25 
could explain cellular fitness effects [56,57]. We also need to keep in mind that yeast 
is a unicellular organism and not all conclusions may be applicable to mammalian and 
other multicellular organisms. 
The difference in animal sizes is mainly due to the difference in cell number 
rather than cell size. This suggests that maintaining a specific cell size may be more 30 
beneficial (or at least easier) than to generate large organisms by increasing cell size. 
Nevertheless, it is possible to select or engineer animals with abnormally large cells 
by taking advantage of a ploidy increase. These animals can be fully polyploid or may 
contain polyploid cells in otherwise normal diploid tissue. Such animals could be very 
useful for analyzing how cell size affects organismal functionality, for example, how 35 
do fewer large cells compare to many small cells in the metabolism or physiological 
function of a tissue. So far this has not been widely done. In the 1940’s Gerhard 
Fankhauser generated polyploid Eastern newts [Notophthalmus (Triturus) 
viridescens] by heat modulation of the fertilized eggs. His work established the 
correlation between ploidy and cell size and also revealed that organ and organismal 40 
size control is distinct from cell size control. Curiously, he observed that the triploid 
newts with 50% larger cells performed poorly in learning studies, indicating cognitive 
problems associated with larger cell size [58]. Further work has attempted to 
generalize these findings by correlating cell size with brain complexity in other 
amphibian species and thus providing supporting evidence that too large cell size is a 45 
burden for brain function [59]. More recently, comparisons of diploid and triploid 
animals has revealed that especially in aquatic environments triploid animals tend to 
have a reduced metabolic rate, despite maintaining same organismal size [60], 
suggesting a potential fitness disadvantage for abnormally large cell size. 
Polyploidy can also be found in a subset of mammalian tissues even under 50 
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normal conditions. Whole organismal polyploidy in mammals is usually lethal, but 
polyploidization is common particularly in hepatocytes during development [61]. The 
increased DNA content and associated larger hepatocyte size is considered normal for 
liver for functional reasons that remain incompletely understood. However, there is a 
cost to polyploidization as polyploid cells may be genetically unstable [62]. Several 5 
stress factors may induce polyploidization in differentiated diploid hepatocytes, such 
as regeneration after partial hepatectomy, oxidative stress, metabolic imbalance, 
chemical damage, or viral infection [63] (Fig. 3A). Therefore, as with yeast, 
hepatocyte polyploidy can be used to increase genetic variability, which would help in 
adaptation to chronic stress and damage [64]. 10 
Many different genetic mouse models have been used to generate polyploid 
hepatocytes and other cell types [64]. We have taken advantage of cyclin-dependent 
kinase 1 (Cdk1), which controls DNA re-replication in polyploid hepatocytes during 
liver regeneration after partial hepatectomy [65]. Through a conditional deletion of 
Cdk1 in hepatocytes, we generated a mouse model with increased genome content 15 
and cell size due to the DNA re-replication phenotype [66]. As Cdk1 is essential for 
cell division, the resection of up to 70% of the liver mass (partial hepatectomy) 
followed by liver regeneration can be used to further increase cell size [66,67] (Fig. 
3B & 3C). The benefit of this genetic model for analyzing cell size is that the animals 
are isogenic and that any direct effects of Cdk1 on cell size can be largely excluded by 20 
comparing to the Cdk1 null and wild-type livers before partial hepatectomy [67]. 
Analysis of these mice indicated that the relative expression of most mitochondrial 
genes, whether encoded by the mitochondrial or the nuclear genome, was reduced in 
large hepatocytes. This finding is consistent with metabolic allometry. 
Our data also indicated that increased hepatocyte size and nuclear DNA 25 
content in hepatocytes is strongly associated with reduced expression of genes 
involved in lipid synthesis and increased glycolysis [67]. This implicates that in 
hepatocytes with increase in cell size and polyploidy, mitochondrial activity is 
reduced and ATP production likely compensated by enhanced glycolytic activity, 
resulting in substantial metabolic remodeling. Interestingly, the relationship between 30 
hepatic DNA content and lipid metabolism is comparable to non-alcoholic fatty liver 
disease patients who display a significant increase in polyploid hepatocytes [68]. 
Moreover, it has been observed that the increase in polyploidy in hepatocytes during 
NAFLD progression is due to excess of lipids causing increased oxidative stress [68], 
which is indicative of mitochondrial malfunction [69]. 35 
Supporting our in vivo observations, we noticed that mitochondrial 
functionality declines with increasing cell size in a manner dependent on 
mitochondrial dynamics, i.e., how mitochondria fuse and divide. This was observed in 
many different cultured cell types during the normal cell cycle, providing further 
evidence for cell size dependent metabolism [46,48]. Misregulation of oxidative 40 
phosphorylation has been associated with liver damage and liver failure (reviewed in 
[70]). While we have not yet experimentally challenged our animals to directly 
analyze the fitness of their liver, it appears that metabolism, nuclear DNA content and 
cell size during liver regeneration could be connected to organ and organismal fitness. 
 45 
Biophysical mechanisms connecting cell size to fitness and functionality 
Through what mechanisms could size influence growth, metabolism and 
cellular functionality? From a biophysical perspective, there are three common 
explanations for why too large cell size is not optimal: the structural integrity of the 
cells, the increased intracellular distances, and the reduced surface-to-volume (SV) 50 
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ratio. These factors can lead to metabolic inefficiency (Fig. 2) and cell death. These 
biophysical factors alone do not explain how or why each cell type has its own 
characteristic size. Cell type specific features, such as structure of the cytoskeleton or 
mitochondrial network morphology [48], likely influence how each cell type is 
dependent on biophysical limitations and what the optimal size for that cell type is. 5 
First, structural integrity of cells could affect cell size and fitness. A stronger 
cytoskeleton is required to support larger cells [71]. Consistently, we have observed 
increased transcription of cytoskeletal genes in response to cell size increase [67]. 
However, the structural integrity of the plasma membrane might become limiting for 
the largest cells as the thickness of the membrane cannot scale with increasing cell 10 
volume. The mechanical strength of cells has not been widely studied in the context of 
cell size, but abnormally large hepatocytes appear unstable upon isolation, which is 
consistent with the idea of structural integrity limiting maximal cell size (M.J.C and 
P.K. unpublished). 
Second, size induced increases in intracellular distances could limit almost all 15 
cellular functions. In larger cells, the diffusion and active transport of molecules and 
cellular components will take longer (Fig. 4A & 4B). As nutrients are consumed most 
in the center of the cell, where nucleus, most ribosomes and mitochondria are typically 
localized, this should create an intracellular gradient of metabolites, as has been 
observed with oxygen [72]. Consequently, the rate of biochemical reactions is 20 
reduced, thus making larger cells less metabolically active. Diffusion rates in 
cytoplasm (Fig. 4C) have been extensively studied and increase exponentially with 
distance (see [73] for review). Unfortunately, there is little quantitative evidence 
regarding the extent to which increased intracellular distances affect growth rate, 
metabolic rate or cell size, although mathematical models suggest that at least the 25 
maximal cell size is limited by intracellular transport [33,74]. Within the micrometer 
scale of most cells, this may not be intuitive, but considering a complete metabolic 
pathway, the diffusion distances required for metabolism could become significant. 
This is because the intracellular localization of some metabolic enzymes and 
organelles require metabolites to travel from one location to another before the whole 30 
metabolic route is completed (Fig. 4B). 
Third, with increasing cell volume, the relative surface area declines (Fig. 4A 
& 4D). Reduced SV ratio is predicted to slow down nutrient and oxygen uptake and 
waste disposal on cellular and organismal level. Cells also need to maintain ionic 
gradients across the plasma membrane by actively pumping ions across the membrane 35 
to counteract ion leakage. For example, cells maintain high potassium and low sodium 
concentration inside the cell. As ion leakage through the plasma membrane depends on 
membrane area, cells with high SV ratio to use relatively more energy for upholding 
the ion balance.  
 40 
Can surface-to-volume ratio control metabolism at the cellular level? 
Our gene expression data from different sized hepatocytes did not show any 
systematic upregulation of ion transporters or other plasma membrane proteins in 
larger cells [67]. This suggests that abnormally large cell did not try to counteract the 
reduced SV ratio and nutrient uptake at the level of membrane proteins. Instead, the 45 
data indicated a strong downregulation of genes involved in lipid biosynthesis [67], 
consistent with the reduced plasma membrane area in larger cells. It is not known 
whether cells can sense their SV ratio, although the molecular mechanisms for this are 
easy to envision. For example, the levels of intracellular cholesterol, one of the lipids 
mainly located in the plasma membrane, could act as a signaling molecule reporting 50 
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the relative amount of plasma membrane in comparison to cytosolic volume. When 
excess intracellular cholesterol accumulates, it is sensed by the sterol regulatory 
element-binding proteins (SREBPs). SREBPs, in turn, control the activity of lipid 
synthesis pathways, including the mevalonate pathway, which produces cholesterol 
[75]. SREBPs could therefore couple SV ratio to membrane production [67].  5 
There is still an ongoing debate if the SV ratio is behind the observed size-
dependent metabolism at the organismal level (reviewed by [38]). Due to experimental 
limitations, there is mostly modeling based support for this on a cellular level. One 
potential way for studying the SV ratio would be comparison of polyploid cells 
obtained through inhibition of cell division to those obtained through cell fusion. 10 
Recent evidence from macrophages suggests that increasing cell size through cell 
fusion results in large amounts of excess plasma membrane [76]. In contrast, cells that 
become polyploid and large by normal growth in the absence of cell division should 
have less surplus membrane (although they may have excess lipids for building 
membranes) and thus substantially lower SV ratio compared to fused cells. In addition, 15 
mechanically restraining cells to specific shapes could be potentially used as an 
experimental system to study the influence of SV ratio on cellular metabolism. 
The changes in SV ratio and intracellular distances also suggest that spherical 
cell shapes, where the relative plasma membrane area is minimized and intracellular 
distance from cell surface to the middle of the cell maximized, should be least optimal 20 
for a large cell. Consequently, complex cell shapes should be beneficial for large cells 
when active metabolism is required. The largest cell types in animals tend to be 
elongated (e.g., muscle cells) and often also branched (e.g., neurons). Yet, there are 
some individual cell types, like oocytes, which are very large and have spherical shape 
with a low SV ratio. How oocytes differ in their nutrient supply and metabolism is an 25 
interesting question in need of more research. Overall, the diversity of SV ratios seen 
in different human cells is extensive (Fig. 4D), and more systematic analyses of SV 
ratios and metabolic parameters in different cells may help elucidate the importance of 
SV ratio and intracellular distances. If cell size and growth is indeed limited by the SV 
ratio and/or the intracellular distances, these limitations may only become meaningful 30 
in larger cell types. This could partly explain the vastly different size-dependent 
growth patterns seen between small single-celled organisms and typically larger 
metazoan cells. 
 
Emerging links between cell size and metabolic disease 35 
As discussed above, we have potential biophysical mechanisms (the SV ratio) 
and an increasing understanding of molecular processes (mitochondrial metabolism) 
related to cell size changes. Yet, we should not forget how these are linked to the 
potential physiological consequences for being the wrong cell size. With age, many of 
us develop chronic diseases such as cancer, type II diabetes, cardiovascular problems, 40 
neurodegenerative diseases or obesity. Is cell size a driver, a passenger or both in 
metabolic conditions? While it is easy to claim that in most of these diseases there is a 
metabolic defect that drives the pathological phenotype, we should not ignore the 
evidence for cell size dependent functionality that has been slowly accumulating 
(reviewed in [16,48]). 45 
Mitochondrial dysfunction in age-related metabolic diseases is well 
documented [77]. The mevalonate pathway may be yet another important cell size 
related player in some common metabolic diseases [75,78]. The mevalonate pathway 
affects cell size (Fig. 5A), changes mitochondrial functionality and mitochondrial 
dynamics (Fig. 5B) [46,79], and is required for normal autophagy [10], resulting in 50 
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cell size dependent changes in metabolism (Fig. 5C). Interestingly, cholesterol 
synthesis alone does not explain mevalonate pathway effects on cell size [10]. The 
mevalonate pathway is also responsible for making other products including heme, 
ubiquinone and steroid hormones as well as geranylgeranyl and farnesyl groups for 
post-translational modification of membrane proteins, which are used not only for 5 
plasma membrane, but for other processes as well, including mitochondrial electron 
transport. Nevertheless, the lipophilic nature of the mevalonate pathway products 
further suggests that the metabolic control of cell size is linked to membranes as 
suggested by work in prokaryotes [80,81]. 
It is conceivable that the disease connections related to cell size changes arise 10 
from changes in mitochondrial metabolism and the mevalonate pathway [10,46,67]. 
Thus, cell size effects on metabolism and cellular fitness may be useful for 
understanding certain aspects of these diseases. Consider the mevalonate pathway – 
cell size association.  Inflammation is a signature of cellular injury and thus a potential 
indicator of reduced cellular fitness. Inflammation is also an important contributor to 15 
the pathogenesis of diabetes and many cancers [82-84]. Increased cell size, such as 
observed during compensatory growth of pancreatic beta-cells in insulin resistance 
[85], may be linked to reduction in mevalonate pathway activity [10,67], which 
induces an inflammatory response [86-88] (Fig. 5D). The mevalonate-pathway 
regulated inflammatory cytokines such as interleukin 1 beta, interleukin 6, and tumor 20 
necrosis factor alpha [88] could thus trigger an infiltration of inflammatory cells to 
tissues with abnormally large cells. It is also well established that cholesterol 
metabolites such as 25-hydroxy-cholesterol directly influence interleukin 1 beta 
expression [89] indicating an additional connection between cell size and 
inflammation at the tissue level. Another condition where cell size changes induce 25 
inflammation is obesity, which is associated with infiltration of inflammatory cells 
(mainly macrophages) into adipose tissue. The level of leukocyte infiltration is directly 
proportional to the adipocyte cell size [90] and both experimental and disease-related 
evidence suggests mevalonate pathway involvement [10,46,67,90]. 
 30 
Conclusions 
We are still lacking a comprehensive view on how and why cell size is 
controlled. While progress in proliferating cell types has been good, size control 
mechanisms in non-proliferating cells remain less well understood. Despite this, there 
is a slowly increasing understanding that cell size affects cellular metabolism and 35 
fitness. This may indeed be the very reason why cell size control is required.  
Changes in cell size and cell size variability are commonly observed in many 
disease conditions and during aging. Because current evidence suggests that cellular 
fitness is often, although not likely always, dependent on mitochondrial metabolic 
activity, it will be important to probe the biomedical significance of cell size control. 40 
We speculate that cell size changes during aging and in metabolic disease are not just 
correlations but manifestations of the same underlying mechanisms; problems in cell 
size control and associated metabolism. If so, then cell size could provide a novel 
framework for understanding some of the metabolic disease phenotypes and to 
suggest improved preventive and therapeutic strategies. The role of mevalonate 45 
pathway in inflammatory response is one example of this school of thinking. 
Altogether, cell size homeostasis may have emerged to function as a protective 
property that helps cells to maintain active metabolism and maximal fitness needed 
for organismal survival. 
 12 
Future research should focus on examining the underlying molecular and 
biophysical mechanisms that result in size dependent changes of metabolism, and 
conversely, metabolic changes resulting in cell size changes. Also, our knowledge of 
which cellular functions are affected by cell size remains limited. Expanding these 
questions to non-proliferating cells and in vivo models will be challenging but critical 5 
for revealing how cell size control contributes to the organismal health and wellbeing. 
Polyploid organisms as well as genetically mosaic animals are likely to be the key 
models enabling the studies on size control mechanisms in multicellular organisms.  
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 Example Arising problem Solution 
Defining 
‘cell size’ 
Cell size has been 
measured as volume, area, 
cell length or an indirect 
measure, such as protein 
content. 
Changes in cellular composition 
and shape can influence the 
results. Data normalization to 
different measures of cell size can 
significantly alter conclusions.   
Consider what is the most 
appropriate measure of 
size for the question. 
Validate the results using 






Cell size is commonly 
studied using E. coli, 
fission or budding yeast, 
or cultured mammalian 
cancer cells. Non-
proliferating cells are 
rarely used.  
There is unlikely to be a single 
universal solution for managing 
cell size, although similar 
biophysical limitations are likely 
to apply. Also, cultured cancer 
cells may have by-passed normal 
size control mechanisms. 
Validate findings in 
different model 
organisms and use 
primary cells and in vivo 
models, when possible.  
Cell size vs  
cell cycle 
Cells become larger at 
later stages of cell cycle, 
thus many cell cycle 
arrests appear to increase 
cell size if cell growth is 
unaffected. 
Assumed cell size regulation or 
size dependent function may 
reflect a cell cycle effect.  
Control for cell cycle 
changes in cell size 
studies.  
Cell size vs 
growth  
Growth regulation can be 
studied independently of 
cell cycle by first blocking 
cell cycle and then 
perturbing size.  
If normal cell cycle is inhibited, 
then cell size changes reflect 
growth regulation. This does not 
automatically mean that cell size 
would change when cell cycle is 
active. 
If the goal is to find size, 
not growth, regulators, 
validate that the cell size 
effects are observed also 





Cell size effects obtained 
through perturbing growth 
pathway may only be 
limited to conditions, 
where this pathway is 
active. 
Nutrients and environmental 
conditions affect cell size, cell 
cycle and cell size perturbations. 





Larger cells typically grow 
faster in absolute terms 
(see Fig. 1). This is similar 
to saying that humans are 
stronger than ants and 
ignoring the size 
difference. 
With many biological questions 
the data requires size 
normalization. Otherwise one may 
conclude that bigger is always 
better. 
 
Consider the biological 
question and normalize 
data accordingly. Also, 
consider what is the 
correct size measure to 







One may try to study cell 
size dependent 
functionalities by first 
making cells smaller or 
larger. 
The size perturbation makes the 
data circumstantial. Cell size 
cannot be changed without 
possibly affecting the function of 
interest.  
Utilize the pre-existing 
variability in cell sizes. 




Figure 1. The need for cell size normalisation of growth rate 
A: An example of a L1210 mouse leukemia cell growth rate through the interphase. 
These cells are rapidly growing with the total cell cycle time being ~11 h. Growth rate 
was obtained by continuously measuring the cells’ buoyant mass using suspended 5 
microchannel resonators as in [31]. The obtained mass measurements (black dots) 
were used to plot a trend line (red line) of the growth rate as a function of time from 
cell division (“birth”). Without normalisation of growth to cell size/mass it would be 
easy to conclude that larger cell size is advantageous, as the absolute growth rate is 
higher.  10 
B: Same data as panel A, except the growth rate was normalised to the cell mass at 
each time point. After normalisation, it is obvious that larger cell size does not mean 
more growth per unit of mass (i.e., growth is not exponential throughout the cell 
cycle), which often is the underlying biological question. 
 15 
Figure 2. Cellular fitness changes with cell size 
Cellular fitness of many cell types displays a maximum at the intermediate size range 
in the population [46], indicating that there is an optimal size range. This range, where 
at least some of cellular functions are maximised, reflects also an optimal size range 
for progression through the cell cycle, as the largest and smallest cells within a 20 
population have reduced proliferative capacity in cultured cells [46]. Some of the 
potential mechanisms why too small or too large cells may display a fitness 
disadvantage and limitations to the metabolic rate are highlighted below. 
  
Figure 3. Hepatocyte polyploidisation and effects of Cdk1 on hepatocyte size and 25 
metabolism 
A: Hepatic polyploidy is common during liver development and results in increased 
cell size. However, cellular damage also induces hepatocyte polyploidy, suggesting 
that polyploidisation is also used for cellular adaptation. It is not clear whether this is 
a two-way regulation, i.e., ploidy increasing oxidative stress and metabolic 30 
overloading. 
B: Liver regeneration in the presence and absence of Cdk1. Before partial 
hepatectomy, hepatocytes display low cellular turnover, while maintaining high 
metabolic rates. At this point normal diploid hepatocytes display a balance between 
glycolytic rate and mitochondrial oxidative phosphorylation (OxPhos). During liver 35 
regeneration, when hepatocytes grow in size and prepare for division, mitochondrial 
OxPhos is reduced and glycolysis is enhanced. Mitochondrial OxPhos and glycolysis 
return to their normal levels after cell division. In the Cdk1Liv-/- hepatocyte 
regeneration results in increase in ploidy and cell size, while mitochondrial OxPhos is 
further reduced and glycolysis increased after partial hepatectomy. This suggests that 40 
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the changes in cellular energy metabolism are dependent on cell size and/or ploidy  
rather than on regeneration or proliferation. 
C: Hematoxylin&Eosin stained histological sections before and after partial 
hepatectomy. Liver regeneration in the absence of Cdk1 results in massive increases 
in cell size as evidenced by the highly enlarged hepatocyte nuclei in the Cdk1Liv-/- 5 
after partial hepatectomy (PH). 
 
Figure 4. Cell size and shape dependent biophysical limitations to growth and 
functionality 
A: Cell size and shape affect surface-to-volume (SV) ratio and intracellular distances. 10 
As many key features of cells metabolism, like protein synthesis and transcription, 
take typically place close to the center of the cell, a spherical shape in large cells may 
generate intracellular metabolite and nutrient gradients. While oxygen levels are 
higher close to the cell surface [72], the gradient directionality might be reversed for 
“waste” products such as lactate. Thus, complex non-spherical shapes may provide a 15 
fitness advantage to large cells. Large spherical cells may display reduced metabolic 
fitness compared to cells having elongate or other more elaborate shapes. The upper 
right corner displays plasma membrane stained B-cells, which have a spherical 
morphology typical for many small animal cells. 
 20 
B: Effect of intracellular distances to metabolism. Amino acids, glucose and oxygen 
travel via diffusion whereas organelles are moved using active transport. Travel time 
with diffusion in a three dimensional space will increase exponentially with the 
distance, i.e., travel time is proportional to (∝) the square of the distance. Instead, 
travel time with active, directional transport will increase linearly with the distance 25 
(see [73] for a review). The total distance of a metabolic route relying on diffusion 
can be surprisingly long. For example, glucose must travel much more than just the 
radius of the cell when being used as an energy source for growth. The first metabolic 
enzyme in glycolysis, hexokinase (HK), is typically bound to mitochondria [91]. 
From there glucose-6-phosphate (glucose-6-P) has to travel to each other enzyme in 30 
glycolysis, and then back to mitochondria for ATP production. The ATP molecules 
need to reach ribosomes or other sites of energy consumption before the original 
energy stored in glucose is converted in to biomass and growth. Metabolism is 
therefore strongly affected by intracellular distances. Appropriate intracellular 
localization of cellular components may help cells grow larger. 35 
C: Log-log plot of travel times and distances for active directional transport (axonal 
transport) and diffusion of different sized molecules in cytoplasm illustrates the 
challenge for diffusion-mediated process in large cells [73,92,93]. 
 
D: Log-log plot of typical SV ratios and volumes of different cell types ([94] and 40 
references within). The blue line displays the SV ratio for a perfect sphere. The SV 
ratios areas at which most bacteria, yeast and human cells occupy are highlighted in 
green, yellow and red, respectively. The vast differences in SV ratios are likely to 
affect metabolic activity and functionality. Note that, for example, the human embryo 
 16 
has very low SV ratio, but this is increases approximately 22% with every cell division 
in the blastomere [95], which may be critical to support growth in the early embryo. 
 
 
Figure 5. The mevalonate pathway affects cell size, metabolism and immune 5 
response 
 
A: Mevalonate pathway inhibition using cholesterol lowering drugs statins increases 
cell size in human and Drosophila cells as analysed by flow cytometry (see ref [10]). 
Note that statins inhibit an early part in the mevalonate pathway, thus reducing the 10 
levels of numerous lipophilic metabolites required for normal mitochondrial function, 
cell signaling, autophagy and plasma membrane synthesis [10,46,79,86,87]. It is 
worth pointing out that high concentrations of statins can severe toxicity, which 
reduces cell size, and different cell types have vastly different sensitivity to statins 
[10]. 15 
 
B: Statins influence mitochondrial dynamics in human cells. Jurkat cell mitochondria 
(green) were imaged after mevalonate pathway inhibition with statins. Plasma 
membrane is shown in red. Image from ref [46], reproduced under CC BY 4.0 license. 
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C: The mevalonate pathway affects cell size dependent metabolism as exemplified by 
statin effects on two parameters of oxygen consumption, maximal and ATP producing 
respiration. Flow cytometry based cell size distributions are shown below as a 
reference. Data is from ref [46]. 
 25 
D: A potential mechanism for cell size dependent induction of inflammation. 
Abnormally large cell size is associated with reduced mevalonate pathway activity 
[10,67]. The mevalonate pathway inhibition induces expression of inflammatory 
cytokines such as interleukin 1 beta (IL-1β) [86,87]. These cytokines activate 
leukocytes to infiltrate into tissues displaying loss of size homeostasis (hepatocytes in 30 
this case), resulting in tissue inflammation. As inflammation can further downregulate 
the mevalonate pathway [86,87], this may induce a feedback causing further increase 
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